Atb Cap Markets Estimates Organigram Q1 Earnings

Organigram Holdings Inc. (NASDAQ:OGI) – Investment analysts at Atb Cap Markets issued their Q1 2025 earnings per share (EPS) estimates for Organigram in a report issued on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes forecasts that the company will post earnings per share of ($0.02) for the quarter. The consensus estimate for Organigram’s current full-year earnings is ($0.20) per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.03) EPS and FY2025 earnings at ($0.07) EPS.

Organigram Price Performance

OGI opened at $1.56 on Monday. Organigram has a fifty-two week low of $1.21 and a fifty-two week high of $2.91. The company has a market capitalization of $196.80 million, a P/E ratio of -3.71 and a beta of 1.02. The firm’s fifty day moving average price is $1.61 and its two-hundred day moving average price is $1.67.

Organigram (NASDAQ:OGI) last released its quarterly earnings data on Wednesday, December 18th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). Organigram had a negative net margin of 45.57% and a negative return on equity of 16.76%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Tidal Investments LLC raised its holdings in shares of Organigram by 8.3% in the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock worth $3,526,000 after buying an additional 149,171 shares in the last quarter. AdvisorShares Investments LLC grew its position in Organigram by 11.8% in the second quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock valued at $1,540,000 after acquiring an additional 105,468 shares during the period. Renaissance Technologies LLC raised its stake in Organigram by 40.8% during the second quarter. Renaissance Technologies LLC now owns 816,948 shares of the company’s stock worth $1,258,000 after acquiring an additional 236,700 shares in the last quarter. Finally, Toronto Dominion Bank lifted its holdings in shares of Organigram by 803.7% during the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock valued at $30,000 after acquiring an additional 14,876 shares during the period. Institutional investors own 34.63% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.